Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 205 to 210 of 210 entries
Sorted by: Best Match Show Resources per page
Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: A population-based study using the IMPACT cohort.

Cancer

Coltin H, Rapoport A, Baxter NN, Nagamuthu C, Nathan PC, Pole JD, Momoli F, Gupta S.
PMID: 34524686
Cancer. 2022 Jan 15;128(2):326-334. doi: 10.1002/cncr.33926. Epub 2021 Sep 15.

BACKGROUND: Adolescents and young adults (AYAs) with cancer may experience elevated rates of high-intensity end-of-life (HI-EOL) care. Locus-of-care (LOC) disparities (pediatric vs adult) in AYA end-of-life (EOL) care are unstudied.METHODS: A decedent population-based cohort of Ontario AYAs diagnosed between...

Cite
Coltin H, Rapoport A, Baxter NN, et al. Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: A population-based study using the IMPACT cohort. Cancer. 2021;128(2):326-334doi: 10.1002/cncr.33926.
Coltin, H., Rapoport, A., Baxter, N. N., Nagamuthu, C., Nathan, P. C., Pole, J. D., Momoli, F., & Gupta, S. (2022). Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: A population-based study using the IMPACT cohort. Cancer, 128(2), 326-334. https://doi.org/10.1002/cncr.33926
Coltin, Hallie, et al. "Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: A population-based study using the IMPACT cohort." Cancer vol. 128,2 (2022): 326-334. doi: https://doi.org/10.1002/cncr.33926
Coltin H, Rapoport A, Baxter NN, Nagamuthu C, Nathan PC, Pole JD, Momoli F, Gupta S. Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: A population-based study using the IMPACT cohort. Cancer. 2022 Jan 15;128(2):326-334. doi: 10.1002/cncr.33926. Epub 2021 Sep 15. PMID: 34524686.
Copy Download .nbib Format: NLM
Thirty years of hip fracture incidence in Austria: is the worst over?.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Dimai HP, Reichardt B, Zitt E, Concin H, Malle O, Fahrleitner-Pammer A, Svedbom A, Brozek W.
PMID: 34392387
Osteoporos Int. 2022 Jan;33(1):97-104. doi: 10.1007/s00198-021-06086-z. Epub 2021 Aug 15.

Nationwide hip fracture incidence in the Austrian population was assessed over a period of 30 years (1989-2018), including 20 years data from a previous study and a recent 10 years follow-up. While absolute numbers in men continued to increase,...

Cite
Dimai HP, Reichardt B, Zitt E, et al. Thirty years of hip fracture incidence in Austria: is the worst over?. Osteoporos Int. 2021;33(1):97-104doi: 10.1007/s00198-021-06086-z.
Dimai, H. P., Reichardt, B., Zitt, E., Concin, H., Malle, O., Fahrleitner-Pammer, A., Svedbom, A., & Brozek, W. (2022). Thirty years of hip fracture incidence in Austria: is the worst over?. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 33(1), 97-104. https://doi.org/10.1007/s00198-021-06086-z
Dimai, Hans Peter, et al. "Thirty years of hip fracture incidence in Austria: is the worst over?." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 33,1 (2022): 97-104. doi: https://doi.org/10.1007/s00198-021-06086-z
Dimai HP, Reichardt B, Zitt E, Concin H, Malle O, Fahrleitner-Pammer A, Svedbom A, Brozek W. Thirty years of hip fracture incidence in Austria: is the worst over?. Osteoporos Int. 2022 Jan;33(1):97-104. doi: 10.1007/s00198-021-06086-z. Epub 2021 Aug 15. PMID: 34392387.
Copy Download .nbib Format: NLM
Real-Time and Adaptive Reservoir Computing With Application to Profile Prediction in Fusion Plasma.

IEEE transactions on neural networks and learning systems

Jalalvand A, Abbate J, Conlin R, Verdoolaege G, Kolemen E.
PMID: 34115598
IEEE Trans Neural Netw Learn Syst. 2021 Jun 11; doi: 10.1109/TNNLS.2021.3085504. Epub 2021 Jun 11.

Nuclear fusion is a promising alternative to address the problem of sustainable energy production. The tokamak is an approach to fusion based on magnetic plasma confinement, constituting a complex physical system with many control challenges. We study the characteristics...

Cite
Jalalvand A, Abbate J, Conlin R, et al. Real-Time and Adaptive Reservoir Computing With Application to Profile Prediction in Fusion Plasma. IEEE Trans Neural Netw Learn Syst. 2021;doi: 10.1109/TNNLS.2021.3085504.
Jalalvand, A., Abbate, J., Conlin, R., Verdoolaege, G., & Kolemen, E. (2021). Real-Time and Adaptive Reservoir Computing With Application to Profile Prediction in Fusion Plasma. IEEE transactions on neural networks and learning systems, . https://doi.org/10.1109/TNNLS.2021.3085504
Jalalvand, Azarakhsh, et al. "Real-Time and Adaptive Reservoir Computing With Application to Profile Prediction in Fusion Plasma." IEEE transactions on neural networks and learning systems vol. (2021). doi: https://doi.org/10.1109/TNNLS.2021.3085504
Jalalvand A, Abbate J, Conlin R, Verdoolaege G, Kolemen E. Real-Time and Adaptive Reservoir Computing With Application to Profile Prediction in Fusion Plasma. IEEE Trans Neural Netw Learn Syst. 2021 Jun 11; doi: 10.1109/TNNLS.2021.3085504. Epub 2021 Jun 11. PMID: 34115598.
Copy Download .nbib Format: NLM
Placental superoxide dismutase 3 mediates benefits of maternal exercise on offspring health.

Cell metabolism

Kusuyama J, Alves-Wagner AB, Conlin RH, Makarewicz NS, Albertson BG, Prince NB, Kobayashi S, Kozuka C, Møller M, Bjerre M, Fuglsang J, Miele E, Middelbeek RJW, Xiudong Y, Xia Y, Garneau L, Bhattacharjee J, Aguer C, Patti ME, Hirshman MF, Jessen N, Hatta T, Ovesen PG, Adamo KB, Nozik-Grayck E, Goodyear LJ.
PMID: 33770509
Cell Metab. 2021 May 04;33(5):939-956.e8. doi: 10.1016/j.cmet.2021.03.004. Epub 2021 Mar 25.

Poor maternal diet increases the risk of obesity and type 2 diabetes in offspring, adding to the ever-increasing prevalence of these diseases. In contrast, we find that maternal exercise improves the metabolic health of offspring, and here, we demonstrate...

Cite
Kusuyama J, Alves-Wagner AB, Conlin RH, et al. Placental superoxide dismutase 3 mediates benefits of maternal exercise on offspring health. Cell Metab. 2021;33(5):939-956.e8doi: 10.1016/j.cmet.2021.03.004.
Kusuyama, J., Alves-Wagner, A. B., Conlin, R. H., Makarewicz, N. S., Albertson, B. G., Prince, N. B., Kobayashi, S., Kozuka, C., Møller, M., Bjerre, M., Fuglsang, J., Miele, E., Middelbeek, R. J. W., Xiudong, Y., Xia, Y., Garneau, L., Bhattacharjee, J., Aguer, C., Patti, M. E., Hirshman, M. F., Jessen, N., Hatta, T., Ovesen, P. G., Adamo, K. B., Nozik-Grayck, E., & Goodyear, L. J. (2021). Placental superoxide dismutase 3 mediates benefits of maternal exercise on offspring health. Cell metabolism, 33(5), 939-956.e8. https://doi.org/10.1016/j.cmet.2021.03.004
Kusuyama, Joji, et al. "Placental superoxide dismutase 3 mediates benefits of maternal exercise on offspring health." Cell metabolism vol. 33,5 (2021): 939-956.e8. doi: https://doi.org/10.1016/j.cmet.2021.03.004
Kusuyama J, Alves-Wagner AB, Conlin RH, Makarewicz NS, Albertson BG, Prince NB, Kobayashi S, Kozuka C, Møller M, Bjerre M, Fuglsang J, Miele E, Middelbeek RJW, Xiudong Y, Xia Y, Garneau L, Bhattacharjee J, Aguer C, Patti ME, Hirshman MF, Jessen N, Hatta T, Ovesen PG, Adamo KB, Nozik-Grayck E, Goodyear LJ. Placental superoxide dismutase 3 mediates benefits of maternal exercise on offspring health. Cell Metab. 2021 May 04;33(5):939-956.e8. doi: 10.1016/j.cmet.2021.03.004. Epub 2021 Mar 25. PMID: 33770509; PMCID: PMC8103776.
Copy Download .nbib Format: NLM
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.

JAMA oncology

Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, Armstrong L, Blood KA, Brossard J, Brunga L, Cacciotti C, Caswell K, Cellot S, Clark ME, Clinton C, Coltin H, Felton K, Fernandez CV, Fleming AJ, Fuentes-Bolanos N, Gibson P, Grant R, Hammad R, Harrison LW, Irwin MS, Johnston DL, Kane S, Lafay-Cousin L, Lara-Corrales I, Larouche V, Mathews N, Meyn MS, Michaeli O, Perrier R, Pike M, Punnett A, Ramaswamy V, Say J, Somers G, Tabori U, Thibodeau ML, Toupin AK, Tucker KM, van Engelen K, Vairy S, Waespe N, Warby M, Wasserman JD, Whitlock JA, Sinnett D, Jabado N, Nathan PC, Shlien A, Kamihara J, Deyell RJ, Ziegler DS, Nichols KE, Dendukuri N, Malkin D, Villani A, Foulkes WD.
PMID: 34617981
JAMA Oncol. 2021 Dec 01;7(12):1806-1814. doi: 10.1001/jamaoncol.2021.4536.

IMPORTANCE: Prompt recognition of a child with a cancer predisposition syndrome (CPS) has implications for cancer management, surveillance, genetic counseling, and cascade testing of relatives. Diagnosis of CPS requires practitioner expertise, access to genetic testing, and test result interpretation....

Cite
Goudie C, Witkowski L, Cullinan N, et al. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncol. 2021;7(12):1806-1814doi: 10.1001/jamaoncol.2021.4536.
Goudie, C., Witkowski, L., Cullinan, N., Reichman, L., Schiller, I., Tachdjian, M., Armstrong, L., Blood, K. A., Brossard, J., Brunga, L., Cacciotti, C., Caswell, K., Cellot, S., Clark, M. E., Clinton, C., Coltin, H., Felton, K., Fernandez, C. V., Fleming, A. J., Fuentes-Bolanos, N., Gibson, P., Grant, R., Hammad, R., Harrison, L. W., Irwin, M. S., Johnston, D. L., Kane, S., Lafay-Cousin, L., Lara-Corrales, I., Larouche, V., Mathews, N., Meyn, M. S., Michaeli, O., Perrier, R., Pike, M., Punnett, A., Ramaswamy, V., Say, J., Somers, G., Tabori, U., Thibodeau, M. L., Toupin, A. K., Tucker, K. M., van Engelen, K., Vairy, S., Waespe, N., Warby, M., Wasserman, J. D., Whitlock, J. A., Sinnett, D., Jabado, N., Nathan, P. C., Shlien, A., Kamihara, J., Deyell, R. J., Ziegler, D. S., Nichols, K. E., Dendukuri, N., Malkin, D., Villani, A., & Foulkes, W. D. (2021). Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA oncology, 7(12), 1806-1814. https://doi.org/10.1001/jamaoncol.2021.4536
Goudie, Catherine, et al. "Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes." JAMA oncology vol. 7,12 (2021): 1806-1814. doi: https://doi.org/10.1001/jamaoncol.2021.4536
Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, Armstrong L, Blood KA, Brossard J, Brunga L, Cacciotti C, Caswell K, Cellot S, Clark ME, Clinton C, Coltin H, Felton K, Fernandez CV, Fleming AJ, Fuentes-Bolanos N, Gibson P, Grant R, Hammad R, Harrison LW, Irwin MS, Johnston DL, Kane S, Lafay-Cousin L, Lara-Corrales I, Larouche V, Mathews N, Meyn MS, Michaeli O, Perrier R, Pike M, Punnett A, Ramaswamy V, Say J, Somers G, Tabori U, Thibodeau ML, Toupin AK, Tucker KM, van Engelen K, Vairy S, Waespe N, Warby M, Wasserman JD, Whitlock JA, Sinnett D, Jabado N, Nathan PC, Shlien A, Kamihara J, Deyell RJ, Ziegler DS, Nichols KE, Dendukuri N, Malkin D, Villani A, Foulkes WD. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncol. 2021 Dec 01;7(12):1806-1814. doi: 10.1001/jamaoncol.2021.4536. PMID: 34617981; PMCID: PMC8498936.
Copy Download .nbib Format: NLM
Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report.

Pediatric blood & cancer

Chamberlain G, Coltin H, Klaassen RJ, Story E, Abbott LS.
PMID: 34357676
Pediatr Blood Cancer. 2021 Dec;68(12):e29259. doi: 10.1002/pbc.29259. Epub 2021 Aug 06.

No abstract available.

Cite
Chamberlain G, Coltin H, Klaassen RJ, et al. Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report. Pediatr Blood Cancer. 2021;68(12):e29259doi: 10.1002/pbc.29259.
Chamberlain, G., Coltin, H., Klaassen, R. J., Story, E., & Abbott, L. S. (2021). Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report. Pediatric blood & cancer, 68(12), e29259. https://doi.org/10.1002/pbc.29259
Chamberlain, Graham, et al. "Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report." Pediatric blood & cancer vol. 68,12 (2021): e29259. doi: https://doi.org/10.1002/pbc.29259
Chamberlain G, Coltin H, Klaassen RJ, Story E, Abbott LS. Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report. Pediatr Blood Cancer. 2021 Dec;68(12):e29259. doi: 10.1002/pbc.29259. Epub 2021 Aug 06. PMID: 34357676.
Copy Download .nbib Format: NLM
Showing 205 to 210 of 210 entries